BIOCAPTIVA Provides Update and Remains on Track to Transform the Liquid Biopsy Market for Cancer Management

BIOCAPTIVA Provides Update and Remains on Track to Transform the Liquid Biopsy Market for Cancer Management

Post Views: 203 BIOCAPTIVA Ltd (“BIOCAPTIVA”), a company developing the BioCaptor, a revolutionary cell free DNA (cfDNA) capture device, which has the potential to transform liquid biopsy testing for cancer management, provides an update on the company’s progress since spinning out of the University of Edinburgh in April 2021. The company’s BioCaptor technology, developed from…